POPULARITY
Categories
142 episodes with Microlearning
33 episodes with Microlearning
221 episodes with Microlearning
11 episodes with Microlearning
9 episodes with Microlearning
10 episodes with Microlearning
10 episodes with Microlearning
4 episodes with Microlearning
5 episodes with Microlearning
9 episodes with Microlearning
4 episodes with Microlearning
5 episodes with Microlearning
4 episodes with Microlearning
2 episodes with Microlearning
4 episodes with Microlearning
3 episodes with Microlearning
4 episodes with Microlearning
3 episodes with Microlearning
What happens when 50 million people need endocrine care… but there are only about 4,000 practicing endocrinologists to see the complex cases? In an environment where misinformation is everywhere and specialist capacity is limited, how can an association help clinicians and care teams deliver better outcomes at scale without diluting quality?In this episode of Associations Thrive, host Joanna Pineda interviews Johnnie White, CEO of the American Association of Clinical Endocrinology (AACE). Johnnie discusses:How AACE's membership is ~6,000 worldwide, with predominantly physicians and a growing “endocrine care team” that includes NPs, PAs, pharmacists, and primary care clinicians.The sobering workforce math: “there's not enough endocrinologists” for the volume of diabetes (and other endocrine disorders), and why AACE prioritizes educating the broader care team.How members get access to endocrine-specific education, guidelines, publications, and networking with field experts.The strategic shift from “endocrinologists” to “endocrinology” and how a bigger tent supports care delivery while keeping endocrinologists as the clinical leaders who develop guidelines.AACE's patient-first digital strategy: landing visitors on the patient portal first, then routing clinicians to the healthcare/member portal.How AACE built “patient journeys” (diabetes, thyroid, obesity, and more) to counter misinformation and provide understandable, trustworthy guidance for patients and caregivers.Why AACE's patient content is heavily used not only by patients but also by clinicians who refer patients to it for education and reinforcement.The organization's non-traditional education mix, including podcasts as an accessible channel for timely topics, and microlearning with short modules, tracked for continuing education credit.Johnnie's leadership philosophy, “Mamba Mentality,” is a continuous quest to improve, seek feedback, and empower experts on the team.References:AACE Website
Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia.CME information and select publications here.
199: Moderne Assistenz, smarte Tools und Microlearning, so sieht erfolgreiche Zusammenarbeit 2026 aus! In dieser Podcastfolge sprechen Florian Sandmann-Reetz und Dorothea Steinmetz über moderne Führung, Assistenz auf Augenhöhe und den strategischen Einsatz von Microsoft 365, Copilot und dem neuen Outlook. Du erfährst: - Warum Vertrauen wichtiger ist als Mikromanagement - Wie Aufgabenmanagement mit Outlook, Planner & To Do wirklich funktioniert - Warum das neue Outlook besser ist als sein Ruf - Wie Copilot und KI den Arbeitsalltag verändern - Weshalb Microlearning die Zukunft der Weiterbildung ist Außerdem geht es um Remote-Onboarding, Teamkultur, Delegation und die Rolle der Assistenz im digitalen Wandel. Wenn dich Themen wie Microsoft 365, Copilot, Outlook-Tipps, Assistenz 4.0, Microlearning, KI im Büro und modernes Leadership interessieren, ist diese Folge ein absolutes Muss. Florian Sandmann-Reetz ... ... ist Gründer, Geschäftsführer und Lead-Trainer der ArtReich GmbH und spezialisiert auf Microsoft 365. Er hat in den letzten 30 Jahren über 2.500 Seminare mit über 4.000 Schulungstagen und mehr als 30.000 Teilnehmenden realisiert. Zudem ist er bekannt aus seinen diversen Social-Media-Kanälen, in denen er regelmäßig Tipps & Tricks zu den Tools von Microsoft liefert. Mit der „ArtReich Microlearning-Community" hat er einen Ort geschaffen, der Menschen vernetzt und kompakte Lerninhalte zu allen Themen rund um M365 bietet. Dorothea Steinmetz ... ... hat nach ihrem geisteswissenschaftlichen Studium den Weg in die Assistenz gewählt. Von der persönlichen Assistenz auf Führungsebene bis zur Leitung administrativer Strukturen hat sie ein breites Aufgabenspektrum kennengelernt und schätzt es sehr, dabei ihr Organisationsgeschick, ihre schnelle Auffassungsgabe und ihr Gespür für Menschen einbringen zu können. Sie versteht Assistenz nicht als statische Rolle, sondern als Feld, das sie aktiv und auf Augenhöhe mit der Führungskraft gestaltet. Links:
Since 2014, the L&D Global Sentiment Survey has been a barometer of what's hot and what's not in the Learning & Development profession, guiding people development professionals towards the trends that their peers are most concerned about. In this episode, Donald H Taylor takes a deep dive into the 2026 report and explores in conversation what we should all be taking note of. Take your L&D to the next level Take advantage of thousands of hours of analysis. Hundreds of conversations with industry innovators and 25+ years of hands-on global L&D leadership. It's all distilled into one framework to help you level up L&D. Access the L&D Maturity Model here - https://360learning.com/maturity-model KEY TAKEAWAYS The strongest route to security and impact for L&D is finding real business problems through your network, then designing simple, targeted interventions that change behaviour and performance—whether or not the answer looks like traditional training. L&D cannot afford to anchor it's worth to content production. If it does it risks being commoditised instead of recognised for solving real business problems. AI is more powerful than we thought, it is helping to deliver truly personalised training. Microlearning may feel like “old news” in some markets, but the survey shows it's still emerging and powerful elsewhere. A reminder that L&D practices move at very different speeds across the world. BEST MOMENTS “The future is going to belong to people who understood early on what worked and what didn't work.” “The wrong turn is to go towards focusing on content.” Donald H Taylor Bio A recognised commentator and thinker in the fields of workplace learning and supporting technologies, Donald is committed to helping develop the learning and development profession. Donald has chaired the Learning Technologies Conference in London since 2000 and writes and speaks world-wide about Learning and Development (L&D). His annual L&D Global Sentiment Survey, started in 2014, provides a unique perspective on L&D trends from over 100 countries. He chairs the Workforce Development board for VC firm Emerge Education, and invests in, and advises, several EdTech start-ups. From 2010 to 2021, he chaired the Learning and Performance Institute. He is the author of Learning Technologies in the Workplace, a graduate of Oxford University and in 2016 was awarded an honorary doctorate by Middlesex University in recognition of his work developing the L&D profession. You can follow and contact Donald via: LinkedIn: https://www.linkedin.com/in/donaldhtaylor/ L&D Global Sentiment Survey 2026: https://donaldhtaylor.co.uk/research_base/global-sentiment-survey-2026/ Website: https://donaldhtaylor.co.uk/ VALUABLE RESOURCES The Learning And Development Podcast - https://podcasts.apple.com/gb/podcast/the-learning-development-podcast/id1466927523 L&D Master Class Series: https://360learning.com/blog/l-and-d-masterclass-home ABOUT THE HOST David James David has been a People Development professional for more than 20 years, most notably as Director of Talent, Learning & OD for The Walt Disney Company across Europe, the Middle East & Africa. As well as being the Chief Learning Officer at 360Learning, David is a prominent writer and speaker on topics around modern and digital L&D. CONTACT METHOD Twitter: https://twitter.com/davidinlearning LinkedIn: https://www.linkedin.com/in/davidjameslinkedin L&D Collective: https://360learning.com/the-l-and-d-collective Blog: https://360learning.com/blog L&D Master Class Series: https://360learning.com/blog/l-and-d-masterclass-home This Podcast has been brought to you by Disruptive Media. https://disruptivemedia.co.uk/
Featuring an interview with Dr Hanny Al-Samkari, including the following topics: Mechanism of action and toxicity of the monoclonal antibody ianalumab (0:00) Primary results from VAYHIT2, a randomized, double-blind Phase III trial of ianalumab with eltrombopag for patients with primary immune thrombocytopenia (ITP) after failure of first-line corticosteroid treatment (7:32) Mechanism of action and toxicity of the Bruton tyrosine kinase inhibitor rilzabrutinib (11:52) Reduction in corticosteroid use with rilzabrutinib and sustained response in adults with persistent or chronic ITP in the long-term extension period of the Phase III LUNA3 study (18:46) CME information and select publications
Today we will talk through three main points Early clarity hurts less than delayed confrontation, Respect is built through honest discomfort, Courage now saves repair work later.You can email me at AgileMalayali@gmail.com and connect on LinkedIn https://www.linkedin.com/in/vinodn/ You can also join our Telegram Learning GroupAlso checkout my other Podcasts Other PodcastsPahayan Talks Malayalam PodcastAgile Indian English PodcastVayanalokam Malayalam Book PodcastCinema Malayali Malayalam PodcastEnglish Podcast Penpositive OutclassYouTube ChannelsPahayan Talks Youtube ChannelAgile Malayali YouTube ChannelPenpositive YouTube ChannelAgile Positive Your Tube ChannelAgile Indian YouTube Channel
Featuring an interview with Dr Terence Friedlander, including the following topics: Perioperative durvalumab with neoadjuvant chemotherapy: Health-related quality-of-life outcomes in the NIAGARA trial (0:00) Targeting HER2 in locally advanced or metastatic urothelial carcinoma (5:17) TROP2-targeted antibody-drug conjugates for locally advanced or metastatic urothelial carcinoma (18:19) CME information and select publications
Dr Terence Friedlander discusses the selection and sequencing of therapy for patients with bladder cancer and reviews clinical findings recently presented at the 2025 ESMO Congress.CME information and select publications here.
On this episode of the ASHE Podcast, hosts Dr. Gonzalo Bearman and Dr. Priya Nori speak with Dr. Brittany Lehrer, and Dr. Sophie Katz, about their new study in ASHE, “It’s QuizTime! The impact of web-based microlearning quizzes on guideline-concordant antibiotic duration for pediatric acute otitis media.” They explore the prescribing gap in pediatric acute otitis media that inspired their microlearning approach and discuss why brief, web-based quizzes can be a high-yield stewardship tool in busy outpatient settings. The authors highlight key design elements that drove engagement, share surprising findings from their pre/post evaluation of guideline-concordant antibiotic duration, and offer practical advice for institutions looking to replicate this low-burden, scalable intervention to improve antibiotic prescribing. https://www.cambridge.org/core/journals/antimicrobial-stewardship-and-healthcare-epidemiology/article/its-quiztime-the-impact-of-webbased-microlearning-quizzes-on-guidelineconcordant-antibiotic-duration-for-pediatric-acute-otitis-media/C23CBF28D3DBA0985491820A5DC52382#article
Difficult conversations are not easy and we might be motivated to avoid them. But there is a hidden cost to that, Let us journey there.You can email me at AgileMalayali@gmail.com and connect on LinkedIn https://www.linkedin.com/in/vinodn/ You can also join our Telegram Learning GroupAlso checkout my other Podcasts Other PodcastsPahayan Talks Malayalam PodcastAgile Indian English PodcastVayanalokam Malayalam Book PodcastCinema Malayali Malayalam PodcastEnglish Podcast Penpositive OutclassYouTube ChannelsPahayan Talks Youtube ChannelAgile Malayali YouTube ChannelPenpositive YouTube ChannelAgile Positive Your Tube ChannelAgile Indian YouTube Channel
Featuring an interview with Dr Sagar Lonial, including the following topics: Phase 3 randomized study evaluating teclistamab and daratumumab versus investigator's choice of daratumumab and dexamethasone with either pomalidomide or bortezomib for patients with relapsed/refractory (R/R) multiple myeloma (MM) (0:00) Management of belantamab mafodotin-associated ocular events with dose modifications guided by standard assessments (3:15) Belantamab mafodotin in combination with bortezomib, lenalidomide and dexamethasone for transplant-ineligible patients with newly diagnosed MM (8:00) Other investigational strategies for R/R MM (12:55) CME information and select publications
Dr Sagar Lonial from Winship Cancer Institute in Atlanta, Georgia, discusses recent clinical developments with BCMA-targeted therapy and investigational agents for relapsed/refractory multiple myeloma presented at ASH 2025.CME information and select publications here.
Featuring patient case presentations by Dr Fern Anari and Dr Catherine Fahey, with commentary from Dr Matthew D Galsky, including the following topics: EMBARK trial: Enzalutamide for biochemically recurrent prostate cancer (0:00) Final results from the Phase III PRESTO study: Combined androgen blockade for high-risk biochemically relapsed prostate cancer (4:05) Other novel treatment strategies for patients with metastatic prostate cancer (10:31) CME information and select publications
Dr McKay discusses the selection of and efficacy data with androgen pathway-targeting agents for patients with prostate cancer and reviews recently presented clinical findings from the ESMO Congress 2025.CME information and select publications here.
We all want to be effective but busyness can be our biggest enemy. Let us journey there.You can email me at AgileMalayali@gmail.com and connect on LinkedIn https://www.linkedin.com/in/vinodn/ You can also join our Telegram Learning GroupAlso checkout my other Podcasts Other PodcastsPahayan Talks Malayalam PodcastAgile Indian English PodcastVayanalokam Malayalam Book PodcastCinema Malayali Malayalam PodcastEnglish Podcast Penpositive OutclassYouTube ChannelsPahayan Talks Youtube ChannelAgile Malayali YouTube ChannelPenpositive YouTube ChannelAgile Positive Your Tube ChannelAgile Indian YouTube Channel
Featuring an interview with Dr Terence Friedlander, including the following topics: Final analysis of the Phase III, open-label, randomized POTOMAC trial (0:00) KEYNOTE-905 trial: Perioperative enfortumab vedotin with pembrolizumab for muscle-invasive bladder cancer (MIBC) (5:25) The neoadjuvant gemcitabine intravesical system TAR-200 for patients with MIBC: Primary analysis of the SunRISe-4 trial (14:07) Circulating tumor DNA-guided therapies for MIBC (18:41) CME information and select publications
Dr Terence Friedlander discusses the selection and sequencing of therapy for patients with bladder cancer and reviews clinical findings recently presented at the 2025 ESMO Congress.CME information and select publications here.
Short doesn't automatically mean effective. We dig into the craft of microlearning that actually changes behavior on the job, moving past buzzwords to a clear blueprint you can use this week. You'll hear the green‑yellow‑red fit test, a tight scoping method, and five delivery patterns that make small learning moments do real work without bloating your course catalog.Ready to ship something meaningful in seven days? Try the micro sprint, share your results, and help a teammate build their first win. If this conversation sparked ideas, follow the show, leave a review, and pass it to a colleague who's drowning in long courses and craving lean learning that sticks.
Featuring an interview with Dr Sagar Lonial, including the following topics: KLN-1010: A novel, in vivo gene therapy generating anti-BCMA chimeric antigen receptor T cells (0:00) Phase III DREAMM-7 and DREAMM-8 studies of belantamab mafodotin-based combination therapy for patients with relapsed/refractory (R/R) multiple myeloma (MM) (5:37) Effectiveness of ciltacabtagene autoleucel for patients with R/R MM (11:04) Low-dose tocilizumab for mitigation of the cytokine release syndrome associated with bispecific antibodies (16:04) Talquetamab with teclistamab for patients with R/R MM in Phase Ib of the RedirecTT-1 trial (19:24) CME information and select publications
Dr Sagar Lonial from Winship Cancer Institute in Atlanta, Georgia, discusses recent clinical developments with BCMA-targeted therapy and investigational agents for relapsed/refractory multiple myeloma presented at ASH 2025.CME information and select publications here.
Featuring patient case presentations by Dr Fern Anari and Dr Catherine Fahey, with commentary from Dr Matthew D Galsky, including the following topics: AKT inhibitors for PTEN-deficient de novo metastatic hormone-sensitive prostate cancer (0:00) Radioligand-directed therapy for PSMA-positive metastatic hormone-sensitive prostate cancer (8:18) Radiation therapy in combination with enzalutamide for high-risk localized prostate cancer (13:14) CME information and select publications
Dr Rana R McKay discusses the selection and sequencing of therapy for patients with prostate cancer in a review of recently presented clinical findings from ESMO Congress 2025.CME information and select publications here.
The Windermere Coaching Minute: Episode OverviewMichael Fanning breaks down Week 1 of the AI Micro Learning Challenge, explaining why each daily exercise works and how real estate professionals can immediately apply AI tools to their business all while maintaining client confidentiality and professional judgment.Never input confidential client information into AI. No names, addresses, financial details, or private data. AI is a powerful tool, not a secure vault.Day 1: Market Trend ConversationsUse AI as a thinking partner to translate economist data (like Jeff Tucker's insights) into client-ready talking points. You bring the expertise; AI helps frame the conversation.Day 2: Simplify Complex ConceptsAsk AI to explain topics like 1031 exchanges in simple, memorable terms. AI excels at creating frameworks and analogies you verify accuracy for your market.Day 3: Creative Top-of-Mind StrategiesBrainstorm 10 ways to stay connected without being salesy. From restaurant guides to shred days, AI helps you see opportunities where you might see obstacles.Day 4: Writing Style AnalysisLet AI analyze your voice and help you create content that sounds authentically like you more efficiently. It amplifies your voice, doesn't replace it.Day 5: Reconnection FrameworksGenerate personalized conversation starters for past clients without using any confidential information. AI provides the framework; you add the personal touch.Day 6: Activity OrganizationTransform business development chaos into trackable categories. Perfect for implementing your Foundation 9 activities and winning your weeks.Day 7: Reflection & ApplicationReview what worked, what saved time, and what helped you think differently. You're the craftsman AI is just the tool.Full CMA or pricing analysis without your professional expertiseAnything involving confidential client dataReplacing your professional judgmentDirect client-facing valuations or predictionsWeek 1 isn't about becoming an AI expert it's about gaining a 24/7 thinking partner that helps you draft, brainstorm, organize, and strategize so you can focus on what only you can do: building authentic relationships and providing expert guidance.Ready to start? Grab ChatGPT, Claude, or your AI of choice. Commit to 10-15 minutes daily. Stay curious, look for opportunities, and work smarter, not harder.Want to be on our podcast? Reach out to Michael at fanning@windermere.comBe awesome, help somebody, and make it a great day!The Golden RuleWeek 1 Daily Exercises (10-15 minutes each)What AI Should NOT Be Used ForThe Real Value
Decision Making is crucial to our professional and personal life and yet we struggle at times. Let us journey there.You can email me at AgileMalayali@gmail.com and connect on LinkedIn https://www.linkedin.com/in/vinodn/ You can also join our Telegram Learning GroupAlso checkout my other Podcasts Other PodcastsPahayan Talks Malayalam PodcastAgile Indian English PodcastVayanalokam Malayalam Book PodcastCinema Malayali Malayalam PodcastEnglish Podcast Penpositive OutclassYouTube ChannelsPahayan Talks Youtube ChannelAgile Malayali YouTube ChannelPenpositive YouTube ChannelAgile Positive Your Tube ChannelAgile Indian YouTube Channel
In this episode of SurgOnc Today, Dr. Zhi Ven Fong, of the HPB Disease Site Work Group interviews Dr. Yorick L. van de Pavert about the ENDURO Trial's (surgical vs endoscopic gastrojejunostomy bypass) design, implementation, and primary and secondary endpoints. If you did not check out part 1, please be sure to visit SurgOnc Academy for the full series: https://learn.surgonc.org/courses/112569
In this episode we will talk about identity and job titles and how they get mixed up for many of us. You can email me at AgileMalayali@gmail.com and connect on LinkedIn https://www.linkedin.com/in/vinodn/Also checkout my other Podcasts Other PodcastsPahayan Talks Malayalam PodcastAgile Indian English PodcastVayanalokam Malayalam Book PodcastCinema Malayali Malayalam PodcastEnglish Podcast Penpositive OutclassYouTube ChannelsPahayan Talks Youtube ChannelAgile Malayali YouTube ChannelPenpositive YouTube ChannelAgile Positive Your Tube ChannelAgile Indian YouTube Channel
In this episode we go to our 5th session where we look at the concept of identity and the thought of becoming over achieving. You can email me at AgileMalayali@gmail.com and connect on LinkedIn https://www.linkedin.com/in/vinodn/Also checkout my other Podcasts Other PodcastsPahayan Talks Malayalam PodcastVayanalokam Malayalam Book PodcastCinema Malayali Malayalam PodcastEnglish Podcast Penpositive OutclassYouTube ChannelsPahayan Media Youtube ChannelAgile Malayali YouTube ChannelPenpositive YouTube ChannelAgile Positive Your Tube ChannelAgile Indian YouTube Channel
In this episode of the JuvoHub Podcast, host Jonathan Saar continues the learning theory series by breaking down one of the most misunderstood concepts in education: micro learning. He explores why simply shortening a long lesson isn't true microlearning, how the science of retention shapes effective design, and what educators should consider before restructuring their content. Jonathan also highlights insights from several articles on micro learning, including research on how adults absorb, process, and retain new information. You'll walk away with a clearer understanding of when micro learning works, when it doesn't, and how to design it with intention—not convenience. TLDR: Micro learning isn't “shorter content.” Its purposeful design grounded in how adult learners process information. Key Takeaways 00:00 – Why Micro Learning Became a Buzzword 00:43 – The Real Meaning of Micro Learning 01:30 – Why “Just Shorter” Isn't Micro Learning 03:36 – Breaking Down the Research 04:45 – What True Micro Learning Requires 05:55 – How the Brain Retains Information 06:40 – Applying Micro Learning to Adult Learners 07:32 – Making Intentional Design Decisions 08:13 – When Micro Learning Works—and When It Doesn't 08:50 – Final Thoughts and Invitation to Share Why Micro Learning Design Matters Micro learning continues to influence how educators and organizations shape modern training, but its value depends entirely on intentional design rooted in learning theory. This episode reinforces that micro learning is not simply shorter content—it's a strategic approach that aligns with how adults absorb and retain information. As you refine your training strategy, understanding the science behind micro learning helps you create experiences that are more engaging, more sustainable, and ultimately more effective. Class Dismissed!
In this episode we go to our Fourth session where we look at how discipline beats motivation . You can email me at AgileMalayali@gmail.com and connect on LinkedIn https://www.linkedin.com/in/vinodn/Also checkout my other Podcasts Other PodcastsPahayan Talks Malayalam PodcastVayanalokam Malayalam Book PodcastCinema Malayali Malayalam PodcastEnglish Podcast Penpositive OutclassYouTube ChannelsPahayan Media Youtube ChannelAgile Malayali YouTube ChannelPenpositive YouTube ChannelAgile Positive Your Tube ChannelAgile Indian YouTube Channel
Featuring an interview with Dr Priyanka Sharma, including the following topics: Endocrine therapy for hormone receptor-positive, HER2-negative high-risk localized breast cancer (0:00) Johnston SR et al. monarchE: Primary overall survival (OS) results of adjuvant abemaciclib + endocrine therapy (ET) for HR+, HER2-, high-risk early breast cancer (EBC). ESMO 2025;Abstract LBA13. Durvalumab in combination with neoadjuvant chemotherapy for localized triple-negative breast cancer (TNBC) (3:25) Loibl S et al. Durvalumab in combination with neoadjuvant chemotherapy in early triple-negative breast cancer (TNBC) – Long-term analysis from the GeparNuevo trial. ESMO 2025;Abstract 292MO. Efficacy and safety findings with TROP2-directed antibody-drug conjugates for metastatic TNBC (5:11) Cortés JC et al. Primary results from ASCENT-03: A randomized phase III study of sacituzumab govitecan (SG) vs chemotherapy (chemo) in patients (pts) with previously untreated advanced triple-negative breast cancer (TNBC) who are unable to receive PD-(L)1 inhibitors (PD-[L]1i). ESMO 2025;Abstract LBA20. de Azambuja E et al. Patient-reported outcomes (PROs) with sacituzumab govitecan (SG) + pembrolizumab (pembro) vs chemotherapy (chemo) + pembro in patients (pts) with previously untreated PD-L1+ metastatic triple-negative breast cancer (mTNBC) in the phase III ASCENT-04/KEYNOTE-D19 study. ESMO 2025;Abstract LBA22. Dent R et al. First-line (1L) datopotamab deruxtecan (Dato-DXd) vs chemotherapy in patients with locally recurrent inoperable or metastatic triple-negative breast cancer (mTNBC) for whom immunotherapy was not an option: Primary results from the randomised, phase III TROPION-Breast02 trial. ESMO 2025;Abstract LBA21. CME information and select publications
Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood, Kansas, summarizes the treatment landscape for patients with breast cancer and discusses the implications of recently presented clinical findings from the ESMO Congress 2025. CME information and select publications here.
Featuring an interview with Dr Priyanka Sharma, including the following topics: Patient-reported outcomes from the SERENA-6 trial of camizestrant with a CDK4/6 inhibitor for patients with HR-positive, HER2-negative advanced breast cancer and ESR1 mutations emerging during first-line endocrine-based therapy (0:00) Mayer E et al. Patient-reported outcomes (PROs) from the SERENA-6 trial of camizestrant (CAMI) + CDK4/6 inhibitor (CDK4/6i) for emergent ESR1m during first-line (1L) endocrine-based therapy and ahead of disease progression in patients (pts) with HR+/HER2– advanced breast cancer (ABC). ESMO 2025;Abstract 486MO. Imlunestrant and abemaciclib versus fulvestrant and abemaciclib for ER-positive, HER2-negative advanced breast cancer: An indirect treatment comparison of 3 Phase III trials (3:00) Bidard FC et al. Imlunestrant plus abemaciclib versus fulvestrant plus abemaciclib in estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer (ABC): An indirect treatment comparison (ITC) of three phase 3 trials. ESMO 2025;Abstract 496P . Giredestrant in the treatment of ER-positive, HER2-negative breast cancer: The Phase III evERA Breast Cancer and EMPRESS trials (5:39) Mayer E et al. Giredestrant (GIRE), an oral selective oestrogen receptor (ER) antagonist and degrader, + everolimus (E) in patients (pts) with ER-positive, HER2-negative advanced breast cancer (ER+, HER2– aBC) previously treated with a CDK4/6 inhibitor (i): Primary results of the phase III evERA BC trial. ESMO 2025;Abstract LBA16. Llombart-Cussac A et al. Preoperative window-of-opportunity study with giredestrant or tamoxifen (tam) in premenopausal women with estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) and Ki67≥10% early breast cancer (EBC): The EMPRESS study. ESMO 2025;Abstract 294MO. Capivasertib/fulvestrant as first- and second-line endocrine-based therapy for PIK3CA/AKT1/PTEN-altered HR-positive advanced breast cancer in the CAPItello-291 trial and gedatolisib/fulvestrant with or without palbociclib for HR-positive, HER2-negative, PIK3CA wild-type advanced breast cancer in the VIKTORIA-1 trial.(10:25) Rugo HS et al. Capivasertib plus fulvestrant as first and second-line endocrine-based therapy in PIK3CA/AKT1/PTEN-altered hormone receptor-positive advanced breast cancer: Subgroup analysis from the phase 3 CAPItello-291 trial. ESMO 2025;Abstract 526P. Hurvitz SA et al. Gedatolisib (geda) + fulvestrant ± palbociclib (palbo) vs fulvestrant in patients (pts) with HR+/ HER2-/PIK3CA wild-type (WT) advanced breast cancer (ABC): First results from VIKTORIA-1. ESMO 2025;Abstract LBA17. CME information and select publications
Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood, Kansas, summarizes the treatment landscape for patients with breast cancer and discusses the implications of recently presented clinical findings from the ESMO Congress 2025. CME information and select publications here.
In this episode of The Modern Man Podcast, host Ted Phaeton speaks with Sean Tepper, founder and CEO of Tykr, an investment platform designed to empower users in navigating the stock market. Sean shares his journey from corporate life to entrepreneurship, discussing the challenges and lessons learned along the way. The conversation explores the significance of financial literacy, the distinctions between investing and trading, and the innovative features of Tykr that aim to simplify investing for users. Sean emphasizes the importance of situational awareness in business and investing, and how leveraging technology, including AI, can enhance investment analysis. The episode concludes with insights on the future of Tykr and the importance of doing what you love while also generating revenue. Chapters 00:00 – Billionaire Investors, Not Traders 01:00 – Introduction to The Modern Man Podcast 03:09 – Sean Tepper's Journey into Investing 08:22 – The Transition from Corporate to Entrepreneurship 13:15 – Overcoming Fear and Embracing Risk 19:00 – The Aha Moment in Investing 24:49 – Building Ticker: The Education Piece 30:26 – Micro Learning and Financial Literacy 35:33 – Investing vs. Trading: The Key Differences 38:46 – Future Goals for Ticker and Growth Strategies 39:56 – Leveraging AI in Investment Analysis Tepper’s Links Website: tykr.com Facebook: tykrpro LinkedIn: seantepper Instagram: tykrinvest Free eBook Here: Mastering Self-Development: Strategies of the New Masculine: m2ebook ⚔️JOIN THE NOBLE KNIGHTS MASTERMIND⚔️ https://themodernmanpodcast.com/thenobleknights
In this episode we go to our third session where we look at Emotional Intelligence at Work. We will discuss Self Awareness, Empathy and regulating our emotions. You can email me at AgileMalayali@gmail.com and connect on LinkedIn https://www.linkedin.com/in/vinodn/Other Podcasts you can checkPahayan Talks - A Pahayan Media Malayalam PodcastPenpositive Outclass English Podcast
Featuring an interview with Dr Priyanka Sharma, including the following topics: T-DXd versus trastuzumab emtansine for high-risk HER2-positive primary breast cancer with residual invasive disease after neoadjuvant therapy: Interim analysis of the DESTINY-Breast05 trial (0:00) Geyer C et al. Trastuzumab deruxtecan (T-DXd) vs trastuzumab emtansine (T-DM1) in patients (pts) with high-risk human epidermal growth factor receptor 2–positive (HER2+) primary breast cancer (BC) with residual invasive disease after neoadjuvant therapy (tx): Interim analysis of DESTINY-Breast05. ESMO 2025;Abstract LBA1. DESTINY-Breast11 trial: Neoadjuvant T-DXd alone or followed by paclitaxel/trastuzumab/pertuzumab for high-risk HER2-positive localized breast cancer (5:42) Harbeck N et al. DESTINY-Breast11: Neoadjuvant trastuzumab deruxtecan alone (T-DXd) or followed by paclitaxel + trastuzumab + pertuzumab (T-DXd-THP) vs SOC for high-risk HER2+ early breast cancer (eBC). ESMO 2025;Abstract 291O. Trastuzumab deruxtecan (T-DXd) and pertuzumab versus a taxane, trastuzumab and pertuzumab for HER2-positive advanced or metastatic breast cancer: Additional analyses of the DESTINY-Breast09 trial (10:00) Loibl S et al. Trastuzumab deruxtecan (T-DXd) + pertuzumab (P) vs taxane + trastuzumab + pertuzumab (THP) for patients (pts) with HER2+ advanced/metastatic breast cancer (a/mBC): Additional analyses of DESTINY-Breast09 in key subgroups of interest. ESMO 2025;Abstract LBA18. CME information and select publications
Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood, Kansas, summarizes the treatment landscape for patients with breast cancer and discusses the implications of recently presented clinical findings from the ESMO Congress 2025. CME information and select publications here.
In this episode we go to our second session of looking at Energy Management over Time Management. You can email me at AgileMalayali@gmail.com and connect on LinkedIn https://www.linkedin.com/in/vinodn/Other Podcasts you can checkPahayan Talks - A Pahayan Media Malayalam PodcastPenpositive Outclass English Podcast
This episode is the beginning of a new series that will go over two years. It will be over 5 phases and each phase having a range of videos. Starting the first episode with the habit of continuous learning. The 5 phases will bePhase 1: Self-Management & Growth Phase 2: Collaboration & TeamworkPhase 3: Project & Product ThinkingPhase 4: Systems & Strategic ThinkingPhase 5: Leadership, Management & FrameworksYou can email me at AgileMalayali@gmail.comOther Podcasts you can checkPahayan Talks - A Pahayan Media Malayalam PodcastPenpositive Outclass English Podcast
The Bulletproof Dental Podcast Episode 412 HOSTS: Dr. Peter Boulden GUEST: Cassie Kellner DESCRIPTION In this conversation, Peter Boulden and Cassie Kellner discuss the importance of Standard Operating Procedures (SOPs) in dental practices. They explore how SOPs can enhance efficiency, improve onboarding, and create a better work environment. Cassie shares insights on using Trainual to develop and manage SOPs effectively, emphasizing the need for team involvement and the integration of technology. The discussion also includes success stories and practical tips for implementing SOPs in dental practices. TAKEAWAYS SOPs are essential for creating structure in dental practices. Digital SOPs are more effective than paper manuals. Micro learning is key to engaging team members. Start with the most frequently asked questions to create SOPs. Team involvement in SOP development increases buy-in. Technology can streamline SOP management and training. Creating a playbook is crucial for onboarding new staff. Regular updates to SOPs are necessary for ongoing relevance. AI can assist in creating and managing SOPs. A well-structured playbook enhances patient experience and team clarity. CHAPTERS 00:00 Introduction to SOPs in Dentistry 04:29 The Importance of Digital SOPs 07:29 Understanding SOPs and Micro Learning 10:44 Onboarding and Employee Retention 13:30 Overcoming the Daunting Task of SOP Creation 16:26 Building a Foundation for Your Practice 19:27 Creating Team Buy-In for SOPs 22:33 Templates and Tools for Startups 23:53 Embracing Growth in Dentistry 29:18 The Importance of a Playbook 29:38 Success Stories: Transforming Practices 34:55 Leveraging AI for Efficiency 41:21 Finding Clarity and Support 43:03 Outro REFERENCES Bulletproof Summit Bulletproof Mastermind BPTRAINUAL.com
Great hospitality starts with confident employees. Without them, guest satisfaction—and the bottom line—suffers. That's why I hosted a Hotel Business Hot Topics roundtable with:
Stacey Gelber, VP of Human Resources at Blaze Pizza, joins hosts Paul Barron and Cherryh Cansler live from the Fast Casual Executive Summit to discuss the evolving challenges of building teams in today's restaurant industry. With 270 locations across three countries, Blaze is navigating the complexities of a multigenerational workforce dominated by Gen Z employees who demand work-life balance, mental health support, and authentic culture. Gelber shares how Blaze is revolutionizing training with microlearning modules, leveraging TikTok for recruitment, and opening "Ignite by Blaze"—an innovation incubator restaurant. From managing vocal Gen Z staff to scaling culture across hundreds of franchises, this conversation reveals the HR strategies that are shaping the future of fast-casual dining.#FastCasualNation #BlazePizza #RestaurantHRGet Your Podcast Now! Are you a hospitality or restaurant industry leader looking to amplify your voice and establish yourself as a thought leader? Look no further than SavorFM, the premier podcast platform designed exclusively for hospitality visionaries like you. Take the next step in your industry leadership journey – visit https://www.savor.fm/Capital & Advisory: Are you a fast-casual restaurant startup or a technology innovator in the food service industry? Don't miss out on the opportunity to tap into decades of expertise. Reach out to Savor Capital & Advisory now to explore how their seasoned professionals can propel your business forward. Discover if you're eligible to leverage our unparalleled knowledge in food service branding and technology and take your venture to new heights.Don't wait – amplify your voice or supercharge your startup's growth today with Savor's ecosystem of industry-leading platforms and advisory services. Visit https://www.savor.fm/capital-advisory
Dr. Arup Roy-Burman, Founder and Chief Strategy and Medical Officer of Elemeno Health, is addressing the gap between established medical policies and actual frontline practice. The Elemeno microlearning platform provides just-in-time multimedia content, building confidence in high-risk, low-frequency procedures, helping support knowledge retention, and combating clinician burnout. This modern approach to learning caters to clinicians with shorter attention spans and the expectation of receiving information on the device of their choice when they need it. Arup explains, "My background is as an ICU physician, and I have practiced as an ICU director for 20-plus years. And the challenge that we had in our ICUs is how to keep our teams on the same page with constantly changing information? And on top of that, in the context of constantly changing staff, medicine is full of so many different practices, workflows, and procedures, and we expect our staff to know all of them and to be able to execute on each one of them at the time that they need to. But that's really unrealistic. There's no way that people can stay on top of it. All medical knowledge doubles every 73 days." "When we think about today's generational workforce, as we think about just those of us who have kids, we see that attention spans, as you said, are short. People don't want to sit through a whole classroom. They can't remember that. And the way that people want to learn now and the way that they do learn, it's like one of our clients put it, it's like the "TikTokification of education." How do we deliver information on a mobile device? How do we deliver it in short, bite-sized chunks? Multimedia that you can actually consume in context when you need it." #ElemenoHealth #DigitalHealth #HealthcareInnovation #Microlearning #NurseTraining elemenohealth.com Download the transcript here
Dr. Arup Roy-Burman, Founder and Chief Strategy and Medical Officer of Elemeno Health, is addressing the gap between established medical policies and actual frontline practice. The Elemeno microlearning platform provides just-in-time multimedia content, building confidence in high-risk, low-frequency procedures, helping support knowledge retention, and combating clinician burnout. This modern approach to learning caters to clinicians with shorter attention spans and the expectation of receiving information on the device of their choice when they need it. Arup explains, "My background is as an ICU physician, and I have practiced as an ICU director for 20-plus years. And the challenge that we had in our ICUs is how to keep our teams on the same page with constantly changing information? And on top of that, in the context of constantly changing staff, medicine is full of so many different practices, workflows, and procedures, and we expect our staff to know all of them and to be able to execute on each one of them at the time that they need to. But that's really unrealistic. There's no way that people can stay on top of it. All medical knowledge doubles every 73 days." "When we think about today's generational workforce, as we think about just those of us who have kids, we see that attention spans, as you said, are short. People don't want to sit through a whole classroom. They can't remember that. And the way that people want to learn now and the way that they do learn, it's like one of our clients put it, it's like the "TikTokification of education." How do we deliver information on a mobile device? How do we deliver it in short, bite-sized chunks? Multimedia that you can actually consume in context when you need it." #ElemenoHealth #DigitalHealth #HealthcareInnovation #Microlearning #NurseTraining elemenohealth.com Listen to the podcast here
In this episode of the JuvoHub Podcast, host Jonathan Saar reframes microlearning as skilling, a practical, retention-first approach that turns short lessons into real performance gains. From software rollouts to property takeovers, learn how to deploy 3–4 minute micro-modules that boost confidence, adoption, and results without scheduling marathon trainings. You'll learn: Why “skilling” > “microlearning” for real-world impact How to use data and ops feedback to pick the right micro-topics A simple blueprint for 3–4 minute lessons that actually stick Key Takeaways: 00:00 – Welcome & why this matters 00:15 – Microlearning vs. “skilling” 00:42 – Retention as the north star 01:05 – Data + ops: choosing micro-topics 01:28 – Change management use cases (software, takeovers) 01:58 – The 3–4 minute lesson blueprint 02:27 – Long sessions vs. bite-size learning 02:55 – Track it: engagement & completion 03:20 – When a longer session is worth it 03:50 – Final takeaway & next steps Skill, Don't Just Train Microlearning becomes powerful when it's treated as skilling—focused, 3–4 minute lessons aligned to real tasks, chosen with data, and measured for retention. Use bite-sized modules to support change management, build confidence, and create momentum without long schedules. Start small, track engagement, and compound the wins. Class Dismissed!
ใน episode นี้ จะมาชวนคุณผู้ฟังคุยถึงการทำ Micro-Learning หรือการเรียนรู้ที่ใช้เวลาน้อย แต่ได้ผลจริงสำหรับวัยทำงานที่ยุ่งๆ ซึ่งเอมจะมาเล่าถึง Micro-Learning คืออะไร ทำไมถึงจำเป็นต่อวัยทำงานอย่างเราๆ มีวิธีการและขั้นตอนทำอย่างไร และมี Bonus แถมตอนท้ายถึงเคล็ดลับการเพิ่มพลังให้ Micro-Learning ของเราได้ผลดียิ่งขึ้น ถ้าพร้อมแล้ว เราไปฟังพร้อมๆกันเลยค่ะ
Traditional e-learning isn't working. With only 5–15% completion rates industry-wide, most employees are stuck in “click & sleep” trainings that don't stick. That's why I was so keen to sit down with Matteo Penzo, Co-Founder & CEO of Zick Learn, to talk about how his company is flipping the script on corporate learning. Zick Learn's AI-powered platform transforms training into 2-minute micro lessons delivered right where people already work: Slack, WhatsApp, Teams. The results? On average, clients save 10 hours per employee every month - a massive boost in both productivity and engagement. Here are other topics from our conversation: ✅ How Zick Learn uses AI and UC Berkeley research to create effective microlearning. ✅ The challenges with traditional e-learning completion rates. ✅ How employers can convert existing training materials into micro-lessons. ✅ Zick Learn's ideal clients and its land-and-expand business model, including its main marketing method. ✅ How the team measures, tracks, and optimizes sales efforts using data. ✅ How Zick Learn tailors product demos to prospects' needs and closes deals without relying on discounts. ✅ Matteo's general growth advice for workplace/HR consulting and HR tech businesses. “Curiosity is the number one success in cold calling,” says Matteo. If your organisation is stuck in a training rut - or if you're building your own HR tech business - his insights, both technological and strategic, are well worth heeding. Full show notes here. You can also find the 'A Better HR Business' podcast on all the main podcast players, including Apple Podcasts and Spotify. Feel free to tag in or share the show with any friends who are busy growing an HR-related business (recruitment, employee engagement, diversity & inclusion, HR admin, etc). Website: https://www.zicklearn.com/en LinkedIn: https://www.linkedin.com/in/matteopenzo/ About The A Better HR Business Podcast The A Better HR Business shares strategies, tactics, success stories, and more about marketing for HR consultancies and marketing for HR tech companies, and how to get more clients. Follow the show on Apple Podcasts or Spotify so you don't miss future episodes. For show notes and to see details of our previous guests, check out the podcast page here: www.GetMoreHRClients.com/Podcast HR BUSINESS GROWTH RESOURCES Get the new book - Grow A Successful HR Business Your Way HR Business Growth Hub - HR Business Growth Hub Launch your own business podcast: B2B Podcast Agency VISIT GET MORE HR CLIENTS Want more clients for your HR-related consultancy or HR Tech business? Visit the Get More HR Clients website for articles, newsletters, podcasts, videos, resources, and more at www.getmorehrclients.com.
When every second counts, the right training can make all the difference. Ken Zipovsky, Grants Manager and Technology Coordinator for the Pennsylvania Chiefs of Police Association, joins us to share how the Pennsylvania Virtual Training Network (PAVTN) is transforming law enforcement education. Discover how online training helps officers stay prepared, adapt to new technology, and meet evolving community expectations. Show Notes:Ken Zipovsky from the Pennsylvania Chiefs of Police shares how PAVTN ensures officers have the skills and confidence they need. His key points include the following:Training Saves Lives – Ongoing, quality training ensures officers respond effectively, ethically, and safely in high-pressure situations.Technology is a Game-Changer – From body cameras to VR simulations, modern tools demand updated training strategies.Flexibility Matters – Online platforms like PAVTN make training accessible anytime, reducing scheduling and logistical challenges.Microlearning & Scenario-Based Training are the Future – Short, targeted learning moments and real-world simulations improve knowledge retention and decision-making.Data Drives Improvement – Reporting tools help justify funding, identify training gaps, and shape future initiatives for law enforcement education.Learn more about d'Vinci's work with the Pennsylvania Chiefs of Police Powered by Learning earned Awards of Distinction in the Podcast/Audio and Business Podcast categories from The Communicator Awards and a Gold and Silver Davey Award. The podcast is also named to Feedspot's Top 40 L&D podcasts and Training Industry's Ultimate L&D Podcast Guide. Learn more about d'Vinci at www.dvinci.com. Follow us on LinkedInLike us on Facebook
The new SBCA Academy is live, and user engagement is increasing steadily. In this episode, SBCA's Education Committee Chair, Tony Acampa, and SBCA's Director of Education, Ashley Baker, dive into the transition to the new LMS and the positive changes it's driving. They highlight the shift to micro-learning, improvements to existing courses, and what's on the horizon for education and training. Most importantly, they break down how members can easily access the content and get the most value from these resources.
The Power of Gratitude What if the key to massive business success wasn't about selling harder — but about serving deeper? In this electrifying episode of the Richer Soul podcast, we sit down with Don Williams, a serial entrepreneur, 8-time author, and the voice behind “The Proven Entrepreneur Show.” Don takes us beyond business blueprints and shares the soulful philosophy that's powered his multi-decade journey working with half of the Fortune 500. Raised with baling wire fixes and $5 junkyard fridges, Don grew up with strong Midwestern values and a reverence for saving, service, and self-reliance. But this isn't a story about frugality — it's about learning how to help others help others, and building scalable business success through intention, emotional intelligence, and micro-learning. Key Takeaways: Micro-Learning is the Future of Growth. Don explains how bite-sized learning — done the right way — can teach even complex sales and leadership skills in record time. Sales is a Transfer of Enthusiasm. With a deep background in customer experience, Don reframes sales as something positive: "Enthusiasm sells." Put People First: The Y.O.U & M.E. Values. Don's values are deceptively simple — “You and Me.” It's about putting others first, offering outstanding effort, and staying mission-focused. Helping Others Help Others is the Ultimate Fulfillment. Don's personal mission — and his challenge to listeners — is to create a ripple effect by empowering others to uplift those around them. Money Learning: Frugality With Purpose Don's childhood shaped his relationship with money profoundly. Raised in a family that fixed everything before replacing anything, he inherited values of delayed gratification and practical spending. His grandfather — a slumlord by today's terms — was rich in assets but lived modestly, tracking rental income on brown grocery bags to avoid buying notebooks. This episode reveals how frugal beginnings can fuel entrepreneurial fire — especially when combined with the desire to give and serve. About Don Williams: Don Williams is a business growth strategist, 8x author, and podcast host with a passion for helping others, help others. Over the past 30 years, he has worked with hundreds of Fortune 500 companies, advising them on sales, customer service, and marketing strategies that deliver measurable results. He's also the founder of The Microlearning Academy and The Proven Entrepreneur Show. When not building businesses or writing books, Don lives outside Fort Worth, TX with his wife Leta (a.k.a. “the redhead”), their children, and grandchildren. Key Discussion Points: Don's “perfect” childhood and his frugal, values-driven upbringing. The origin of “You & Me” as a personal and business philosophy. Lessons from a grandfather who tracked rent payments on grocery bags. The power of micro-learning to transform employee performance. How to build emotional connection into the sales process. The real secret to scaling a service-based business. Conclusion: Stop selling, start serving — treat every sales call as a mission to help. Simplify your values — consider Don's Y.O.U. & M.E. model in your business or personal life. Invest in micro-learning — break down your skill-building into short, intentional lessons. Ask this question daily: “How can I help someone else help someone else?” Links: Websites: https://donwilliamsglobal.com https://provenentrepreneurshow.com https://themicrolearningacademy.com Social Media: https://www.facebook.com/profile.php?id=100015725708842 https://www.linkedin.com/in/don-williams-a63375a https://www.instagram.com/don_williams_global/ https://www.tiktok.com/@donwilliamsglobal https://www.youtube.com/@Don-Williams-Global Watch the full episode on YouTube: https://www.youtube.com/@richersoul Richer Soul Life Beyond Money. You got rich, now what? Let's talk about your journey to more a purposeful, intentional, amazing life. Where are you going to go and how are you going to get there? Let's figure that out together. At the core is the financial well-being to be able to do what you want, when you want, how you want. It's about personal freedom! Thanks for listening! Show Sponsor: http://profitcomesfirst.com/ Schedule your free no obligation call: https://bookme.name/rockyl/lite/intro-appointment-15-minutes If you like the show please leave a review on iTunes: http://bit.do/richersoul https://www.facebook.com/richersoul http://richersoul.com/ rocky@richersoul.com Some music provided by Junan from Junan Podcast Any financial advice is for educational purposes only and you should consult with an expert for your specific needs.
© 2020-2026 Ivy Podcast Discovery LLC
